You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-FLT1 (FLT1) Antibodies

Full name:
anti-Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) Antibodies (FLT1)
On www.antibodies-online.com are 291 Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) Antibodies from 36 different suppliers available. Additionally we are shipping FLT1 Proteins (68) and FLT1 Kits (59) and many more products for this protein. A total of 440 FLT1 products are currently listed.
Synonyms:
AI323757, FLT, FLT-1, FLT1, flt1b, sFlt1, VEGFR-1, VEGFR1

Most Popular Reactivities for anti-FLT1 (FLT1) Antibodies

Select your species and application

anti-Mouse (Murine) FLT1 Antibodies:

anti-Human FLT1 Antibodies:

anti-Rat (Rattus) FLT1 Antibodies:

All available anti-FLT1 Antibodies

Go to our pre-filtered search.

Top referenced anti-FLT1 Antibodies

  1. Human Monoclonal FLT1 Primary Antibody for EIA, IF - ABIN115152 : Chi, Hsieh, Hui, Tam: Modified method for double stranded DNA sequencing and synthetic oligonucleotide purification. in Nucleic acids research 1989 (PubMed)
    Show all 3 references for ABIN115152

  2. Human Polyclonal FLT1 Primary Antibody for IF (p), IHC (p) - ABIN725795 : Cheng, Xiang, Yang, Ma, Zhao: Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast. in Cell biochemistry and biophysics 2015 (PubMed)
    Show all 2 references for ABIN725795

  3. Human Monoclonal FLT1 Primary Antibody for IHC (fro), IF - ABIN1109475 : Imbert, Rosnet, Marchetto, Ollendorff, Birnbaum, Pébusque: Characterization of a yeast artificial chromosome from human chromosome band 13q12 containing the FLT1 and FLT3 receptor-type tyrosine kinase genes. in Cytogenetics and cell genetics 1994 (PubMed)
    Show all 2 references for ABIN1109475

  4. Human Polyclonal FLT1 Primary Antibody for IHC (p), WB - ABIN115391 : Ahmed, Li, Dunk, Whittle, Rushton, Rollason: Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. in Growth factors (Chur, Switzerland) 1996 (PubMed)
    Show all 2 references for ABIN115391

  5. Human Polyclonal FLT1 Primary Antibody for IHC, ELISA - ABIN1532085 : Shibuya, Yamaguchi, Yamane, Ikeda, Tojo, Matsushime, Sato: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. in Oncogene 1990 (PubMed)

  6. Human Polyclonal FLT1 Primary Antibody for IHC (p) - ABIN373445 : Hohenstein, Colin, Foellmer, Amann, Brekken, Daniel, Hugo: Autocrine VEGF-VEGF-R loop on podocytes during glomerulonephritis in humans. in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010 (PubMed)

  7. Human Polyclonal FLT1 Primary Antibody for EIA, FACS - ABIN955511 : Wong, Buckman, Clemons, Verma, Dent, Trudeau, Roche, Ebos, Kerbel, Deboer, Sutherland, Emmenegger, Slingerland, Gardner, Pritchard: Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growt in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 (PubMed)

More Antibodies against FLT1 Interaction Partners

Mouse (Murine) Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. data suggest that sFlt-1 may have a therapeutic effect on AS, resulting from suppression of VEGF signaling-mediated recruitment of circulating monocytes/macrophages

  2. that Flt-1 plays a critical role in cardiac hypertrophy induced by pressure overload via the activation of AKT (show AKT1 Antibodies)

  3. Flt-1 appears to play a role in oxidative stress, which promotes apoptosis of trophoblasts

  4. This article reviews the current evidence on the clinical utility of the sFlt-1/PlGF (show PGF Antibodies) ratio at different points in pregnancy and, accordingly, make a proposal for its clinical implementation. [review]

  5. cyclin A1 (show CCNA1 Antibodies) in association with vascular endothelial growth factor receptor 1 (VEGFR1), is required for HSPC (show PSMA7 Antibodies) and their niches to maintain their function and proper interaction

  6. VEGFR1 signaling facilitates angiogenesis in ischemia by recruiting CXCR4 (show CXCR4 Antibodies)+VEGFR1-expressing cells from bone marrow.

  7. The hypoxia-induced rise in sFlt-1 levels seems not to be mediated by IL-6 (show IL6 Antibodies) in vivo.

  8. FLT1 inhibition reduces tumor metastatic efficiency even after initial seeding, suggesting that these pathways represent therapeutic targets in metastatic disease.

  9. Vandetanib treatment can reduce arteriosclerosis induced by abdominal aorta transplantation by blocking VEGFR1 and VEGFR2 (show KDR Antibodies) in endothelial progenitor cells

  10. Tumor-derived VEGF-A (show VEGFA Antibodies), PLGF-2 (show PGF Antibodies), and VEGF-B (show VEGFB Antibodies) augment pain sensitivity through selective activation of VEGF receptor 1 (VEGFR1) expressed in sensory neurons in human cancer and mouse models.

Human Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. Findings indicate that hnRNP (show HNRNPC Antibodies) D and arginine methylation play important roles in the regulation of Flt-1 mRNA alternative polyadenylation.

  2. the target gene FLT1 regulated by miRNA-30e-3p and miRNA-369-3p may play key role in the progression and development of AD.

  3. High expression of VEGFR1 is associated with astrocytomas.

  4. Our results validate previous findings that suggest VEGFR1-positive cells in benign lymph nodes can predict clinical outcome

  5. soluble fms-like tyrosine kinase-1 and placental growth factor (show PGF Antibodies) as biomarkers in patients with coronary artery disease

  6. VEGFR-1 activation-induced MMP-9 (show MMP9 Antibodies)-dependent invasion in hepatocellular carcinoma

  7. Results show that overexpression of c-MET and its phosphorylation with up-regulation of VEGFR1 are associated with chemo-resistance phenotype of colon cancer.

  8. Higher sFlt-1 and lower VEGF levels in the group with preeclampsia, as well as higher sFlt-1 levels in small for gestational age neonates, reflect a predominance of antiangiogenic mechanisms in preeclampsia and growth restriction.

  9. There is a significant negative correlation between the concentration of sFLt-1 and PlGF (show PGF Antibodies) in normal pregnancy.

  10. High expression levels of VEGFR1 and VEGFR3 (show FLT4 Antibodies) were associated with a higher rate of lung metastasis.

Cow (Bovine) Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. VEGFR-1 negatively regulates primary bovine retinal pericytes survival, and its blockade protects the blood-brain barrier integrity.

  2. gamma-Secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1

  3. VEGFR1 mRNA expression was lower at estrus and at the early I and early II luteal stages than at the other stages, whereas VEGFR1 protein expression did not change significantly throughout the estrous cycle (P<0.05)

  4. Alterations in the expression of VEGF-A (show VEGFA Antibodies) and bFGF (show FGF2 Antibodies) systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.

  5. inhibition of VEGFR-1 results in decrease in number of capillary connections indicating VEGFR-1 ligands promote branching angiogenesis.

  6. TGF-beta1 (show TGFB1 Antibodies) induction of VEGFR-1 in endothelial cells explains pericyte protection of vessels and the selective vulnerability of neonatal vessels to oxygen(VEGFR-1)

  7. the activation of VEGFR-1 and VEGFR-2 (show KDR Antibodies) heterodimer (VEGFR-1/R-2) is essential for PGI(2 (show PTGIR Antibodies)) synthesis mediated by VEGF-A (show VEGFA Antibodies)(165) and VEGF-A (show VEGFA Antibodies)(121), which cannot be reproduced by the parallel activation of VEGFR-1 and VEGFR-2 (show KDR Antibodies) homodimers with corresponding agonists

  8. PEDF (show SERPINF1 Antibodies) and VEGFR-1 have roles in the negative regulation of angiogenesis

Pig (Porcine) Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. we analyzed the expression and cellular distribution of Flt-1(VEGFR-1) and Flk-1 (KDR/VEGFR-2 (show KDR Antibodies))in newborn piglet brain

  2. data shows that members of the VEGF (show VEGFA Antibodies)-VEGFR (show KDR Antibodies) system are temporally and spatially well localized for playing key roles during umbilical cord formation and its intensive growth observed after day 75 of pregnancy

  3. The VEGFR1 was stably expressed during the whole lifespan of mesonephric glomeruli, and VEGFR1 is important for the maintenance of endothelial fenestrations.

  4. increased placental expression of the VEGF receptor system is associated with increased placental vascular density observed with the advancement of gestation in the pig.

  5. EGFR (show EGFR Antibodies), VEGFR (show KDR Antibodies) and FGFR (show FGFR2 Antibodies) are expressed in porcine oviduct and endometrium during the time of implantation [review]

  6. VEGF ligand-receptor system may play an important role in the development and maintenance of the corpus luteum in pigs.

  7. VEGF (show VEGFA Antibodies)/Flk-1 (show KDR Antibodies)/Flt-1 system is activated during myocardial ischemia reperfusion injury.

  8. Hemodialysis graft placement leads to early increases in wall shear stress, VEGF-A (show VEGFA Antibodies), pro-MMP-9 (show MMP9 Antibodies), MMP-2 (show MMP2 Antibodies), VEGFR-1, VEGFR-2 (show KDR Antibodies), and TIMP-1 (show TIMP1 Antibodies), which may contribute to the development of venous stenosis.

  9. in experimental intervertebral disc degeneration, VEGF receptors were expressed in the damaged disc and paradiscal tissues

Zebrafish Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. Flt1-tyrosine kinase (TK) activity contributed significantly in endothelial cells survival and vascular development during embryo angiogenesis in zebrafish by engaging PI3K/Akt (show AKT1 Antibodies) pathway.

  2. Elevated Notch (show NOTCH1 Antibodies) signaling downstream of perturbed VEGF (show VEGFA Antibodies) signaling contributes to aberrant flt-1(-/-) blood vessel formation.

  3. Data indicate that the increase in FLT1/sFLT1 protein levels upon miR-10 (show LILRB2 Antibodies) knockdown inhibited the angiogenic behavior of endothelial cells largely by antagonizing vascular endothelial growth factor receptor 2 (show KDR Antibodies) signaling.

FLT1 Antigen Profile

Antigen Summary

This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.

Alternative names and synonyms associated with FLT1

  • fms-related tyrosine kinase 1 (FLT1) antibody
  • vascular endothelial growth factor receptor 1 (CpipJ_CPIJ012087) antibody
  • FMS-like tyrosine kinase 1 (Flt1) antibody
  • FMS-related tyrosine kinase 1 (Flt1) antibody
  • fms-related tyrosine kinase 1 (Flt1) antibody
  • fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1) antibody
  • fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (flt1) antibody
  • vascular endothelial growth factor receptor-1 (FLT-1) antibody
  • AI323757 antibody
  • FLT antibody
  • FLT-1 antibody
  • FLT1 antibody
  • flt1b antibody
  • sFlt1 antibody
  • VEGFR-1 antibody
  • VEGFR1 antibody

Protein level used designations for FLT1

fms-related tyrosine kinase 1 , vascular endothelial growth factor receptor 1 , embryonic receptor kinase 2 , tyrosine-protein kinase receptor FLT , vascular endothelial growth factor receptor-1 , vascular permeability factor receptor , fms-like tyrosine kinase 1 , fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) , tyrosine-protein kinase FRT , FLT-1 , FMS-like tyrosine kinase 1 , Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) , VEGF-receptor , flt-receptor , vascular endothelial growth factor 1 , vascular endothelial growth factor/vascular permeability factor receptor , ascular endothelial growth factor/vascular permeability factor receptor , VEGFR-1 , flt-1 type VEGF receptor , receptor tyrosine kinase Flt1b , soluble fms-like tyrosine kinase 1

GENE ID SPECIES
443088 Ovis aries
6044537 Culex quinquefasciatus
14254 Mus musculus
2321 Homo sapiens
54251 Rattus norvegicus
100732326 Cavia porcellus
503620 Bos taurus
403727 Canis lupus familiaris
374100 Gallus gallus
396763 Sus scrofa
544667 Danio rerio
443182 Ovis aries
Selected quality suppliers for anti-FLT1 (FLT1) Antibodies
Did you look for something else?